Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Ozelle Unveils AI-Powered Complete Blood Morphology Solution
The all-in-one diagnostic platform combines hematology, biochemistry, and immunoassay testing in a single run.
Flow Cytometry
Latest
BD Partners to Advance Immunotherapy Research Through Flow Cytometry
The company's cell analyzer will enable the investigation of 30-plus cellular characteristics to capture key biological insights and support a planned 1,000-person immune profiling study.
Mass Spectrometry
Latest
New Blood Test Signature Could Improve Type 2 Diabetes Risk Prediction
A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.
Immunoassay
Latest
DPYD Genotyping Assay Receives FDA Breakthrough Device Designation
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
Molecular Diagnostics
Latest
Bipartisan Bill Would Expand Medicaid Coverage for Pediatric Genomic Sequencing
A bipartisan House bill would require Medicaid to cover whole genome and exome sequencing for children with suspected rare diseases, aiming to improve diagnostic access and reduce costs, according to lawmakers and recent pilot programs.
Point-of-Care
Latest
Roche Receives FDA Clearance for Point-of-Care Bordetella Test
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.